Elena Netchiporouk Selected Research

Elena Netchiporouk Research Topics

Disease

10	Chronic Urticaria 05/2024 - 03/2020
8	Neoplasms (Cancer) 09/2023 - 01/2014
6	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2017
4	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2023 - 01/2017
4	Skin Diseases (Skin Disease) 01/2022 - 01/2017
3	COVID-19 04/2024 - 01/2023
3	Infections 10/2023 - 04/2012
3	Hypersensitivity (Allergy) 10/2023 - 01/2016
3	Urticaria (Hives) 10/2023 - 09/2015
3	Systemic Scleroderma (Systemic Sclerosis) 05/2023 - 01/2022
3	Atopic Dermatitis (Atopic Eczema) 01/2022 - 05/2021
2	Exanthema (Rash) 10/2023 - 01/2016
2	Cicatrix (Scar) 01/2023 - 01/2022
2	Psoriatic Arthritis 01/2023 - 11/2022
2	Bullous Pemphigoid (Pemphigoid) 07/2022 - 01/2022
2	Dermatitis 01/2022 - 05/2021
2	Chronic Inducible Urticaria 01/2022 - 10/2021
2	Pruritus (Itching) 05/2021 - 09/2020
2	Eczema 05/2021 - 01/2017
2	Lymphoma (Lymphomas) 01/2021 - 09/2020
2	Pemphigus (Pemphigus Vulgaris) 01/2021 - 09/2020
2	Genomic Instability 01/2019 - 12/2018
1	Asthma and Nasal Polyps 04/2024
1	Pneumonia (Pneumonitis) 04/2024
1	Angioedema 10/2023
1	Mastocytosis 10/2023
1	Injection Site Reaction 10/2023
1	Localized Scleroderma (Morphea) 09/2023
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 09/2023
1	Poroma 09/2023
1	Actinic Keratosis 03/2023
1	Empyema 01/2023
1	Joint Diseases (Joint Disease) 01/2023
1	Alopecia Areata 01/2023
1	Alopecia universalis 01/2023
1	Acrodermatitis (Gianotti Crosti Syndrome) 01/2023
1	Dermatomyositis (Dermatopolymyositis) 12/2022
1	Cutaneous Lupus Erythematosus 12/2022
1	Carcinogenesis 12/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Disease Susceptibility (Diathesis) 01/2022
1	Eosinophilia 01/2022
1	Neurodermatitis (Lichen Simplex Chronicus) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Blister (Bulla) 01/2022
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Cold Urticaria 01/2022
1	Conjunctivitis 05/2021

Drug/Important Bio-Agent (IBA)

8	Omalizumab (Xolair)FDA Link 05/2024 - 09/2015
4	dupilumabIBA 05/2024 - 05/2021
4	Monoclonal AntibodiesIBA 04/2024 - 01/2021
3	CytokinesIBA 01/2023 - 01/2022
3	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2017
2	Immunoglobulin E (IgE)IBA 04/2024 - 01/2022
2	ligelizumabIBA 11/2023 - 03/2020
2	Messenger RNA (mRNA)IBA 10/2023 - 01/2023
2	VaccinesIBA 10/2023 - 09/2019
2	Immune Checkpoint InhibitorsIBA 09/2023 - 01/2021
2	AntigensIBA 01/2023 - 01/2019
2	Minoxidil (Rogaine)FDA LinkGeneric 01/2023 - 01/2020
2	CollagenIBA 12/2022 - 01/2022
2	Histamine Antagonists (Antihistamines)IBA 01/2022 - 10/2021
2	Rituximab (Mabthera)FDA Link 01/2021 - 09/2020
2	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 11/2020 - 06/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 03/2017
2	ParaffinIBA 01/2017 - 01/2017
2	Formaldehyde (Formol)FDA Link 01/2017 - 01/2017
1	Antiviral Agents (Antivirals)IBA 04/2024
1	IceIBA 01/2024
1	COVID-19 VaccinesIBA 10/2023
1	SolventsIBA 05/2023
1	Acitretin FDA Link 03/2023
1	Niacinamide (Nicotinamide)FDA LinkGeneric 03/2023
1	Fluorouracil (Carac)FDA LinkGeneric 03/2023
1	Interleukin-23 (Interleukin 23)IBA 01/2023
1	tildrakizumabIBA 01/2023
1	deucravacitinibIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	InterferonsIBA 12/2022
1	Long Noncoding RNAIBA 12/2022
1	Antirheumatic Agents (DMARD)IBA 11/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022
1	Ustekinumab (CNTO 1275)FDA Link 01/2022
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022
1	AutoantibodiesIBA 01/2022
1	InterleukinsIBA 05/2021

Therapy/Procedure

9	Therapeutics 04/2024 - 01/2014
3	Immunotherapy 09/2023 - 12/2018
2	Radiotherapy 09/2023 - 01/2023
2	Biological Therapy 05/2021 - 03/2020
1	Artificial Respiration (Mechanical Ventilation) 04/2024
1	Drug Therapy (Chemotherapy) 09/2023
1	Lasers (Laser) 09/2023
1	Chemoprevention 03/2023
1	Treatment Delay 11/2022